Dunn Edmund
- SEC CIK
- 0001989401
In the past year, 3 open-market sale filings worth $483.1K and no purchases.
Current role at each company
- GLUE Monte Rosa Therapeutics, Inc.Principal Accounting Officeras of Mar 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $483.1K
- 3 filings
- Net
- −$483.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Dunn Edmund as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Dunn EdmundPrincipal Accounting Officer | SSale | −139 | $17.96 | −$2.50K | −0.6%22.6K after | |
| Mar 2, 2026 (view filing) | Feb 27-Mar 2 | 3 days | Dunn EdmundPrincipal Accounting Officer | SSale | −25.7K | $18.09 | −$464.8K | −53.1%22.7K after | 2 lots |
| Jan 5, 2026 (view filing) | Jan 5 | Same day | Dunn EdmundPrincipal Accounting Officer | SSale | −1.04K | $15.17 | −$15.8K | −4.4%22.7K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Dunn EdmundPrincipal Accounting Officer | SSale | −2.06K | $4.45 | −$9.18K | −8.0%23.7K after | |
| Jul 9, 2024 (view filing) | Jul 5 | 4 days | Dunn EdmundPrincipal Accounting Officer | SSale | −1.61K | $3.83 | −$6.17K | −10.4%13.9K after | |
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Dunn EdmundPrincipal Accounting Officer | SSale | −1.21K | $4.04 | −$4.88K | −7.2%15.6K after |